[1]
S. Ständer, “Quality of Life in Psoriasis Vulgaris: Use of the ItchyQoL Questionnaire in a Secukinumab Phase III Trial in Patients with Psoriasis Vulgaris”, Acta Derm Venereol, vol. 99, no. 12, pp. 1085–1090, Aug. 2019.